Profile photo Janneke van de Wijgert

Janneke van de Wijgert

Full Professor

Strategic program(s):

Biography

Prof. Janneke van de Wijgert, MD PhD MPH, is a translational infectious disease researcher, educated in biomedical sciences and medicine (Utrecht University, Netherlands), and public health epidemiology (University of California at Berkeley, USA). Her work experience includes clinical epidemiological and public health research, laboratory research, and product development worldwide. Former employers include the University of California at San Francisco (5 years of which as Director of the UZ-UCSF Collaborative HIV Research Program in Harare, Zimbabwe), the Population Council in New York, the Amsterdam University Medical Center, and the University of Liverpool, UK. She was appointed Full Professor in the Julius Center for Health Sciences and Primary Care of the University Medical Center (UMC) Utrecht in 2017, and served as Chief Science Officer at the Dutch Institute of Public Health and the Environment (RIVM) from 2022-2024. She has supervised/is supervising multiple PhD and Master's students, and has published more than 200 peer-reviewed papers. 
 
Janneke van de Wijgert’s main areas of research and teaching include 1) general infectious and immune-mediated disease epidemiology (including COVID-19 and post-COVID); 2) the role of the human microbiome in health and disease; 3) the role of the urinary tract microbiome in urinary tract infections; 4) the role of the cervicovaginal microbiome in reproductive and neonatal health and disease, and in prevention of HIV transmission; and 5) evaluation of diagnostics, treatments, and prevention interventions in these areas. In addition to traditional epidemiological approaches, she has specialised in incorporating ‘-omics’ and other complex biological data into epidemiological models. During the COVID-19 epidemic, she has worked with eHealth applications to control epidemic spread as well as vaccination and diagnostic studies. She is currently the PI of the RECLAIM post-COVID adaptive platform trial in the Netherlands and the UTIr cohort study.

A complete list of publications can be found on ORCID: https://orcid.org/0000-0003-2728-4560

 

 

Research groups

Infections in general practice

Research aim

To optimise prevention, diagnosis, prognosis and management of common infections in general practice.

Go to group

Recent publications

Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections A Lalmohamed, R P Venekamp, A Bolhuis, P C Souverein, J van de Wijgert, M Gulliford, A D Hay
The Journal of Infection, 2024, vol. 88
Health-related quality of life during the COVID-19 pandemic Cheyenne C E van Hagen, Anne J Huiberts, Elizabeth N Mutubuki, Hester E de Melker, Eric R A Vos, Janneke H H M van de Wijgert, Susan van den Hof, Mirjam J Knol, Albert Jan van Hoek
PLoS ONE, 2024, vol. 19
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024 Anne J Huiberts, Christina E Hoeve, Brechje de Gier, Jeroen Cremer, Bas van der Veer, Hester E de Melker, Janneke Hhm van de Wijgert, Susan van den Hof, Dirk Eggink, Mirjam J Knol
Eurosurveillance, 2024, vol. 29
Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination Juana Claus, Thijs Ten Doesschate, Esther Taks, Priya A Debisarun, Gaby Smits, Rob van Binnendijk, Fiona van der Klis, Lilly M Verhagen, Marien I de Jonge, Marc J M Bonten, Mihai G Netea, Janneke H H M van de Wijgert
Vaccines, 2024, vol. 12
High adherence to intermittent and continuous use of a contraceptive vaginal ring among women in a randomized controlled trial in Kigali, Rwanda Evelyne Kestelyn, Jennifer Ilo Van Nuil, Marie Michelle Umulisa, Grace Umutoni, Alice Uwingabire, Irith De Baetselier, Mireille Uwineza, Stephen Agaba, Tania Crucitti, Thérèse Delvaux, Janneke H H M van de Wijgert
Frontiers in global women's health, 2024, vol. 5
Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis Stephanie Ramboarina, Tania Crucitti, Katherine Gill, Linda Gail Bekker, Emma Michele Harding-Esch, Janneke H H M van de Wijgert, Bich-Tram Huynh, Camille Fortas, Aina Harimanana, Théodora Mayouya Gamana, Rindra Vatosoa Randremanana, Reziky Mangahasimbola, Chido Dziva Chikwari, Katharina Kranzer, Constance R S Mackworth-Young, Sarah Bernays, Nicola Thomas, David Anderson, Fatime Ramla Tanko, Monalisa Manhanzva, Micaela Lurie, Fezile Khumalo, Edina Sinanovic, Ayako Honda, Tanya Pidwell, Suzanna C Francis, Lindi Masson, Jo-Anne Passmore,
BMJ Open, 2024, vol. 14